EUVIMEDEUVIMED entdecken
Crossref

Anti-EGFR Aptamer-Conjugated Erythrocyte Membrane-Derived Nanoparticles for Targeted Doxorubicin Delivery

Do Hyun Lee, Kangchan Choi iD, Ji Won Lee, Min Woo Kim, Yong Serk Park, Moon Jung Choi iD

Molecular Pharmaceutics · 06.04.2026 · 23 (4) · 2792-2804

DOI: 10.1021/acs.molpharmaceut.5c01966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 25.03.2026. Verfasst von Do Hyun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Laboratory Science, Yonsei University, Wonju 26493, South Korea. Hauptthemen laut MEDLINE: Doxorubicin, Aptamers, Nucleotide, Nanoparticles, Erythrocyte Membrane. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinAptamers, NucleotideNanoparticlesErythrocyte MembraneHumansAnimalsFemaleErbB ReceptorsMiceCell Line, TumorDrug Delivery SystemsDrug CarriersMice, NudeXenograft Model Antitumor AssaysAntibiotics, Antineoplastic

Stichwörter der Autor:innen

anti-EGFR aptamererythrocyte-derived nanoparticles (EDNs)nanomedicineoxorubicintriple-negative breast cancer. (TNBC)

Substanzen

DoxorubicinAptamers, NucleotideErbB ReceptorsDrug CarriersEGFR protein, humanAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Biomedical Laboratory Science, Yonsei University, Wonju 26493, South Korea.
  • The DABOM Inc., Seoul 03722, South Korea.
  • School of Medicine, Trinity Medical Sciences University, Warner Robins, Georgia 31093, United States.
  • Department of Surgery, Yonsei University College of Medicine, Seoul 03722, South Korea.
  • Division of Hematology and Oncology, Department of Medicine, Rhode Island Hospital and The Warren Alpert Medical School of Brown University, Providence, Rhode Island 02903, United States.

ORCID-Profile: Kangchan Choi, Moon Jung Choi

Zitieren

APA

Lee, D. H., Choi, K., Lee, J. W., Kim, M. W., Park, Y. S., & Choi, M. J. (2026). Anti-EGFR Aptamer-Conjugated Erythrocyte Membrane-Derived Nanoparticles for Targeted Doxorubicin Delivery. Molecular Pharmaceutics, 23(4), 2792-2804. https://doi.org/10.1021/acs.molpharmaceut.5c01966

Vancouver

Lee DH, Choi K, Lee JW, Kim MW, Park YS, Choi MJ. Anti-EGFR Aptamer-Conjugated Erythrocyte Membrane-Derived Nanoparticles for Targeted Doxorubicin Delivery. Molecular Pharmaceutics. 2026;23(4):2792-2804. doi:10.1021/acs.molpharmaceut.5c01966

BibTeX
@article{Lee2026,
  author = {Lee, Do Hyun and Choi, Kangchan and Lee, Ji Won and Kim, Min Woo and Park, Yong Serk and Choi, Moon Jung},
  title = {Anti-EGFR Aptamer-Conjugated Erythrocyte Membrane-Derived Nanoparticles for Targeted Doxorubicin Delivery},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {4},
  pages = {2792--2804},
  doi = {10.1021/acs.molpharmaceut.5c01966}
}
Kostenlos starten →